US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Amgen (NQ:AMGN)

403.04 -4.23 (-1.04%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now. ↗
Alphabet is a great company, but its dividend payout is underwhelming. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
This ETF Has More Than Doubled the S&P 500's Returns Over the Past Decade. Is It a Buy for the Next Decade? ↗
It may not duplicate those impressive results, but it has all the tools it needs. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
I Correctly Predicted Alphabet Would Join the Dow Jones Industrial Average in June. Here's What the Index Shake-Up Means for Investors. ↗
Honeywell's spin-off was the catalyst for replacing Verizon with Alphabet in the Dow Jones Industrial Average. 
Via The Motley Fool
Topics Stocks
News headline image
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
Wednesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Discover which dow jones stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds. 
Via The Motley Fool
News headline image
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. ↗
The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout. 
Via MarketBeat
Topics ETFs
News headline image
2 Underrated Weight Loss Stocks to Buy and Hold ↗
They look well-positioned to grab a slice of the fast-growing anti-obesity market. 
Via The Motley Fool
Which dow jones stocks are moving on Monday? ↗
Via Chartmill
Top dow jones movers in Monday's session ↗
Via Chartmill
News headline image
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? ↗
Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet. 
Via The Motley Fool
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
Top dow jones movers in Tuesday's session ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Friday. ↗
Via Chartmill
News headline image
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. ↗
New cancer therapies may help fund dividend growth. 
Via The Motley Fool
Topics Intellectual Property
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Discover which dow jones stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure ↗
Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for... 
Via MarketBeat
Topics ETFs Intellectual Property
News headline image
2 S&P 500 Stocks with Competitive Advantages and 1 Facing Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Economy Energy Stocks
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
The Smartest Dividend ETF to Buy With $1,000 Right Now -- and It's Up 19% in 2026 ↗
This low-fee fund offers a glorious mix of growth and income. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Amgen: A Biotech Giant's Path to Recovery and Growth ↗
Join us as we dissect Amgen's stock performance and management strategies. Is this biotech giant poised for growth, or is it facing significant challenges ahead? 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
72 73 Next >